VistaGen Therapeutics Inc (VTGN) financials · rev $1.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
VistaGen Therapeutics Inc (VTGN) rev $1.3M.
| Line | FY2026 | FY2024 |
|---|---|---|
| Revenue | $1.27M | $1.06M |
| Operating Income | -$72.1M | -$33.0M |
| Net Income | -$69.7M | -$29.4M |
| EPS (Diluted) | -$1.83 | -$1.52 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $48.6M | $84.3M |
| Current Assets | $46.9M | $82.1M |
| Cash & Equivalents | $30.8M | $67.1M |
| PP&E | $427.0K | $476.0K |
| Total Liabilities | $13.0M | $14.0M |
| Current Liabilities | $12.8M | $12.6M |
| Shareholders' Equity | $35.5M | $70.4M |
| Retained Earnings | -$477.3M | -$407.6M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$66.4M | -$42.1M |
| Investing Cash Flow | -$877.0K | -$13.1M |
| Financing Cash Flow | $31.0M | $3.21M |
| Net Change in Cash | -$36.3M | -$52.0M |
FAQ
What is VTGN P/E and revenue?
VistaGen Therapeutics Inc (VTGN) rev $1.3M.
What is VTGN revenue?
VistaGen Therapeutics Inc last cached revenue is $1.27M (FY2026).
Is VTGN profitable?
VistaGen Therapeutics Inc last cached net income is -$69.7M (FY2026).
What are VTGN total assets?
VistaGen Therapeutics Inc last cached total assets are $48.6M (FY2026).
What is VTGN free cash flow?
No cached cash-flow row for VTGN yet.
Not investment advice. Cached statements, not a live tape.